Uncommon Therapeutics
YC W25San Francisco, US · Founded 2024 · 2 employees · 2 known investors
Uncommon Therapeutics uses advanced technologies to develop drugs targeting rare genetic diseases, starting with Rett Syndrome, a neurodevelopmental disorder affecting approximately 1 in 10,000 girls. The company combines disease expertise with efficient drug development to advance therapeutics from discovery to clinical application.
BiotechHealthtechLongevityMedical DevicesGene TherapyCRISPRBiotechnologyUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W25)
Uncommon Therapeutics was founded in 2024 by Noah Auerhahn and Ryan Lim.
NA
Noah AuerhahninFounder & CEONoah Auerhahn is Founder of Uncommon Therapeutics, which develops therapeutics for rare genetic diseases including Rett Syndrome.
Investors · 2
In the news
Frequently asked questions
- What does Uncommon Therapeutics do?
- Uncommon Therapeutics uses advanced technologies to develop drugs targeting rare genetic diseases, starting with Rett Syndrome, a neurodevelopmental disorder affecting approximately 1 in 10,000 girls. The company combines disease expertise with efficient drug development to advance therapeutics from discovery to clinical application.
- Who founded Uncommon Therapeutics?
- Uncommon Therapeutics was founded by Noah Auerhahn, Ryan Lim in 2024.
- Who are Uncommon Therapeutics's investors?
- Uncommon Therapeutics's investors include Moonfire Ventures, Y Combinator.
- Where is Uncommon Therapeutics headquartered?
- Uncommon Therapeutics is headquartered in San Francisco, US.